Shenzhen, China

Peng Gao

This inventor holds 12 USPTO granted patents and 7 published patent applications and 12 EPO patents. Top assignees: Ping an Technology (Shenzhen) Co., Ltd., Huawei Technologies Co., Limited, Huawei Technologies Co., Ltd.. Active years: 2012-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peng Gao. Retrieved from https://idiyas.com/inventor/peng-gao-o9lw6kbe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 12 

% Patents Active = 91.7

 

Average Co-Inventor Count = 4.1

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Shenzhen, CN (2012 - 2024)
  • Guangdong, CN (2024)

Company Filing History:


Years Active: 2012-2026

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: The Innovative Journey of Inventor Peng Gao

Introduction

Peng Gao, a notable inventor based in Shenzhen, China, holds an impressive portfolio of 11 patents. His contributions primarily lie in the fields of artificial intelligence and biotechnology. With a commitment to innovation, Gao has developed groundbreaking technologies that enhance the capabilities of medical imaging and antibody production.

Latest Patents

Among Peng Gao's latest patents is a significant advancement in the medical field titled "Method, device, electronic equipment and storage medium for positioning macular center in fundus images." This invention relates to artificial intelligence and offers a method for accurately locating the macular center in fundus images. The innovative approach involves acquiring a detection result from a model that identifies the optic disc and macular areas, calculating their center point coordinates, and correcting the macular area for both left and right eye fundus images.

Additionally, Gao has developed a patent titled "Development of recombinant chicken IGY SCFV antibody raised against human thymidine kinase 1 expressed in prokaryotic cells and use thereof." This invention focuses on the expression of a recombinant chicken IgY scFv antibody against human thymidine kinase 1 (hTK1) in prokaryotic cells. The resulting antibodies exhibit excellent specificity and immunoreactivity, making them valuable for research and potential therapeutic applications.

Career Highlights

Peng Gao has made significant strides in his professional career, having worked with prominent technology companies such as Ping An Technology (Shenzhen) Co., Ltd. and Huawei Technologies Co., Limited. His experiences in these leading firms have equipped him with the skills necessary for conducting impactful research and pushing the boundaries of technology in his areas of expertise.

Collaborations

Throughout his career, Peng Gao has collaborated with esteemed colleagues, including Guotong Xie and Yijun Tang. These collaborations have been instrumental in accelerating innovation, enabling the development of effective solutions to complex problems in the fields of AI and biotechnology.

Conclusion

In conclusion, Peng Gao stands out as a prominent inventor whose work has significantly impacted medical imaging and antibody development. His innovative patents reflect a deep understanding of technology and a commitment to improving healthcare outcomes. As he continues to forge new paths in his research endeavors, the contributions of Peng Gao are sure to inspire future generations of inventors and researchers.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…